Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 9193324

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1997 Apr
First author
Swain SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 1997 Oct;15(10):3293-5. doi: 10.1200/JCO.1997.15.10.3293.
    note
    Source null
    related pmid
    9336370
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2000 May;18(9):2004-6. doi: 10.1200/JCO.2000.18.9.2004.
    note
    Source null
    related pmid
    10784645
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2001 Jul 15;19(14):3439-41. doi: 10.1200/JCO.2001.19.14.3439.
    note
    Source null
    related pmid
    11454894
    relationship
    Comment in

Authors and identifiers

  1. name
    Swain SM
    type
    Author
  2. name
    Whaley FS
    type
    Author
  3. name
    Gerber MC
    type
    Author
  4. name
    Ewer MS
    type
    Author
  5. name
    Bianchine JR
    type
    Author
  6. name
    Gams RA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Swain SM
    type
    Author
  2. name
    Whaley FS
    type
    Author
  3. name
    Gerber MC
    type
    Author
  4. name
    Ewer MS
    type
    Author
  5. name
    Bianchine JR
    type
    Author
  6. name
    Gams RA
    type
    Author
bibliography ids
  1. nci-bib-dc11d39272a6f4c95ea24f14
book metadata
content sha256
589cfc1313914250df4574564415bff7577ab18c0f466b619b2a78390efa5ff0
document type
citation
dois
  1. 10.1200/JCO.1997.15.4.1333
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:9193324
immutable id
pubmed:9193324@589cfc1313914250df4574564415bff7577ab18c0f466b619b2a78390efa5ff0
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
4
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1333-40
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 1997 Oct;15(10):3293-5. doi: 10.1200/JCO.1997.15.10.3293.
    note
    Source null
    related pmid
    9336370
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2000 May;18(9):2004-6. doi: 10.1200/JCO.2000.18.9.2004.
    note
    Source null
    related pmid
    10784645
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2001 Jul 15;19(14):3439-41. doi: 10.1200/JCO.2001.19.14.3439.
    note
    Source null
    related pmid
    11454894
    relationship
    Comment in
outcomes validated
false
pmid
9193324
provenance
batch id
629590480cca3a097fa8
provider
NCBI PubMed ESummary
record sha256
332cf40b00112b1724d82690db4264f318d8d8be93a0d4ac4fb5e39b23159650
response sha256
0eb1cec7011436204408643f1cea7888e97d436038d0a09eaecfd9b32db84919
retrieved at
2026-09-09T23:45:26.993225+00:00
publication date
display
1997 Apr
precision
month
year
1997
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/9193324/
title
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

Preserved source evidence · Not medical advice